NCT01777412: Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations |
|
|
| Completed | 1b | 10 | US | Bevacizumab, Avastin | Johns Hopkins University, Genentech, Inc., Guthy Jackson Charitable Foundation | Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder | 02/15 | 05/15 | | |
